Higher clot rate in younger adults, says UK medicines regulatorpublished at 14:25 British Summer Time 30 April 2021
Robert Cuffe
BBC head of statistics
Data published by the UK drug regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), reveals the number of clots experienced by each age group in the UK after taking the Oxford-AstraZeneca vaccine.
The regulator says they show “higher” rates in younger adults, as has been previously reported, and the MHRA advises that people keep an eye on this “evolving evidence”.
The Financial Times reported this morning that the committee that decides who gets what vaccination, the Joint Committee on Vaccination and Immunisation, is looking closely at the data on clots in those under 40.
The figures from the MHRA show that, overall, the risk of experiencing these unusual clots with low platelets is about a little below one in 100,000.
Up to 21 April, they had seen 27 of these clots in people in their 30s and another 30 among people in their 40s. We don’t have public figures yet on exactly how many people in these precise age groups have been vaccinated.
But the vaccination program has only just opened up to everyone in their 40s.
And the latest figures for England are a reminder how many more older people have been vaccinated, for example 13 million over 60s (with 57 clots reported) compared with seven million people in their 50s (with about the same number of clots reported).